You are here
CAMBRIDGE NEUROSCIENCE
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
N/A
Amount: $436,241.00N/A
SBIRPhase II2000Department of Health and Human Services National Institutes of Health -
N/A
Amount: $0.00N/A
SBIRPhase I2000Department of Health and Human Services National Institutes of Health -
N/A
Amount: $100,000.00Not Available Evolution Enterprises has developed a patent-pending system for genetic programming based on a concise, powerful set of operators which are particularly suitable for evolving programs f ...
SBIRPhase I2000Department of Health and Human Services National Institutes of Health -
SYMPTOMATIC TREATMENT OF PERIPHERAL NEUROPATHIES
Amount: $100,000.00N/A
SBIRPhase I1997Department of Health and Human Services -
NEUREGULIN ANTAGONISTS FOR CANCER TREATMENT
Amount: $100,000.00N/A
SBIRPhase I1997Department of Health and Human Services -
SYNTHETIC NEUROPROTECTIVE GLUTAMATE RELEASE BLOCKERS
Amount: $500,000.00NEURONAL DAMAGE IN ISCHEMIA IS INITIATED BY EXCESSIVE RELEASE OF GLUTAMATE FROM BRAIN NERVE TERMINALS. WE HAVE DISCOVERED, USING NOVEL RAPID KINETIC METHODOLOGY DEVELOPED IN THE P.1.'S LABORATORY, THA ...
SBIRPhase II1993Department of Health and Human Services -
HUMAN HOMOLOGUES OF NEMATODE CELL DEATH GENES
Amount: $500,000.00THE GOAL OF THIS RESEARCH IS TO DEVELOP DIAGNOSTIC REAGENTS AND NEW THERAPEUTICS FOR THE CURE OR PREVENTION OF DEGENERATIVE DISEASES THROUGH THE ISOLATION AND ANALYSIS OF HUMAN GENES IMPLICATED IN THE ...
SBIRPhase II1992Department of Health and Human Services -
STUDY OF GROWTH-ASSOCIATED PROTEINS
Amount: $50,000.00THE OBJECTIVE OF THIS PROJECT IS TO EXAMINE THE MOLECULAR CHANGES THAT UNDERLIE SPINAL CORD REGENERATION IN THE LAMPREY. WE WILL IDENTIFY AND ISOLATE NOVEL GROWTH-ASSOCIATED PROTEINS (GAPS) DERIVED FR ...
SBIRPhase I1992Department of Health and Human Services -
SYNTHETIC NEUROPROTECTIVE GLUTAMATE RELEASE BLOCKERS
Amount: $50,000.00N/A
SBIRPhase I1992Department of Health and Human Services -
NEUROPROTECTIVE ANTAGONISTS OF KAINATE NEUROTOXICITY
Amount: $50,000.00PATHOLOGICAL OVERSTIMULATION OF RECEPTORS FOR THE NEUROTRANSMITTER L-GLUTAMATE IS BELIEVED TO CONTRIBUTE TO THE DEATH OR DEGENERATION OF NERVE CELLS THAT OCCURS IN MANYACUTE AND CHRONIC NEUROLOGICAL D ...
SBIRPhase I1991Department of Health and Human Services